Non-invasive screening testing that reliably detects fetal genetic anomalies at the genome level from maternal blood samples.
NIPTiva Test does not pose a risk to the fetus, and it is also much more reliable than combined screening tests.
Non-invasive screening testing that reliably detects fetal genetic anomalies at the genome level from maternal blood samples.
NIPTiva Test does not pose a risk to the fetus, and it is also much more reliable than combined screening tests.
10 weeks of pregnancy is the most favorable for testing because there is a higher percentage of the baby's DNA in the mother's blood.
Risk-free for the pregnant woman and the baby!